BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business

  February 10, 2026

   · 

  4 min read
• Press Releases

  Calbiotech and Liquid Biosciences Announce Strategic Collaboration to Accelerate Next-Generation Diagnostic Development

  February 10, 2026

   · 

  3 min read
• Press Releases

  Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting

  February 10, 2026

   · 

  3 min read
• Press Releases

  Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

  February 10, 2026

   · 

  4 min read
• Press Releases

  Incyte Reports Fourth Quarter and Full Year 2025 Financial Results

  February 10, 2026

   · 

  19 min read
• Press Releases

  Aardvark Therapeutics Announces FDA Submission and IRB Approval of Amended Trial Protocol for Lead Candidate ARD-101, Expanding Eligibility in Phase 3 Study of Prader-Willi Syndrome

  February 10, 2026

   · 

  6 min read
• Press Releases

  AstraZeneca results: FY and Q4 2025

  February 10, 2026

   · 

  12 min read
• Press Releases

  Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting

  February 10, 2026

   · 

  2 min read
• Press Releases

  Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis

  February 10, 2026

   · 

  9 min read
• Press Releases

  OrsoBio Announces Positive Topline Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and Metabolic Liver Disease

  February 10, 2026

   · 

  3 min read